Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
07/2009
07/15/2009EP1871738B1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
07/15/2009EP1844039B1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
07/15/2009CN101481368A Production method of 5-norbornene-2,3-anhydride
07/15/2009CN101481367A Method for synthesizing natural sesquiterpene Crepis virens extract (8-Epigrosheimin)
07/15/2009CN101481366A Preparation of 2,3,3',4'-biphenyl-tetracarboxylic acid dianhydride and derivatives thereof
07/15/2009CN101480183A Selective herbicides based on substituted arylsulfonylaminocarbonyl triazolinones and safeners
07/15/2009CN100513402C Method for producing 2-oxo-1-phenyl-3-oxabicyclo [3.1.0]hexane
07/15/2009CN100513381C Process for preparation of cyclic diketones
07/15/2009CN100512810C Premixed amiodarone parenteral solution and method for making the same
07/15/2009CN100512809C Compounds and methods of treating transplant rejection
07/14/2009US7560589 Cycloalkylidene compounds as modulators of estrogen receptor
07/14/2009US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
07/14/2009US7560576 Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
07/14/2009US7560572 Therapy for micorbiocide infections; cystic fibrosis; controlling gene expression; antibiotic; immunology stimulant
07/14/2009US7560483 Synthesizing 1- (acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amenable
07/14/2009US7560463 Diaryl ethers as opioid receptor antagonists
07/09/2009WO2009085344A2 Dibenzothiophene, dibenzofuran and/or carbazole-containing materials in phosphorescent light emitting diodes
07/09/2009WO2009084655A1 METHOD FOR PRODUCING 4'-ETHYNYL d4T
07/09/2009WO2009084512A1 Aromatic amine derivative and organic electroluminescent device using the same
07/09/2009WO2009084023A2 Amorphous ramelteon and process for the preparation thereof
07/09/2009WO2009084008A1 Process for preparing mycophenolate mofetil
07/09/2009WO2009028969A9 Lignin and other products isolated from plant material, and methods and compositions therefor
07/09/2009WO2008148747A3 Pdz domain modulators
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176990 Process for producing nitroguanidine derivatives
07/09/2009US20090176895 Multi-Tubular Reactors With Monolithic Catalysts
07/09/2009US20090176873 Novel use of organic compounds
07/09/2009US20090176861 Cathepsin cysteine protease inhibitors
07/09/2009US20090176859 Cathepsin cysteine protease inhibitors
07/09/2009US20090176848 Fortifier
07/09/2009US20090176837 Compounds with activity at retinoic acid receptors
07/09/2009US20090176836 3-{[(3-amino-3-benzyltetrahydrofuran-2-yl)oxy]methyl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[(methylsulfonyl)(propyl)amino]benzamide, used for preventing the formation of insoluble amyloid proteins
07/09/2009US20090176786 Benzoylurea Compounds and Use Thereof
07/08/2009EP2076491A1 New benzamide derivatives as bradykinin antagonists
07/08/2009EP2076252A2 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
07/08/2009EP2076132A1 P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-beta -d-ribofuranosyl)-3h-thiazole [4, 5-d]pyrimidine-2-one and methods for preparation
07/08/2009CN101475548A Method for preparing chiral 3-substituted phthalide compound
07/08/2009CN101475547A Method for synthesizing furanol by catalyzing basic ferric carboxylate
07/08/2009CN101475546A Catalytic synthesis process of benzofurane derivatives
07/08/2009CN101475545A Method for preparing alpha-angelica lactone from acetylpropionic acid
07/08/2009CN101475544A Method for preparing furan chemical by catalytic pyrolysis of biomass
07/08/2009CN101475543A Method for preparing hydroxymethyl-furfural from glucide under low temperature and normal pressure
07/08/2009CN100510093C Method for preparing 3-heteroarylradical-3-hydroxy-propionic acid derivative
07/08/2009CN100509877C Unsaturated monomers, polymers, chemically amplified resist composition, and process of pattern formation
07/08/2009CN100509816C Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar
07/08/2009CN100509791C Compound and use of the compound as glycine transport inhibitors
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009US7557249 Spirobifluorene derivatives, their preparation and uses thereof
07/07/2009US7557223 Titanium-vanadium-tin comprising catalyst and process for the preparation of phthalic anhydride
07/07/2009US7557219 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
07/07/2009US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis
07/07/2009US7556931 Furosemide modulators of HM74
07/07/2009US7556908 Chemically amplified positive resist composition, (meth)acrylate derivative and a process for producing the same
07/02/2009WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy
07/02/2009WO2009081483A1 Oxime esters and photopolymerization initiators containing the same
07/02/2009WO2009080773A1 Convergent synthesis of renin inhibitors and intermediates useful therein
07/02/2009WO2009056993A3 A process for the synthesis of ramelteon and its intermediates
07/02/2009WO2009052970A3 Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
07/02/2009US20090171101 Method for gas phase oxidation using a moderator layer
07/02/2009US20090171095 Production method of heterocyclic mercapto compound
07/02/2009US20090170941 Pharmaceutical Compounds
07/02/2009US20090170902 Compounds which potentiate glutamate receptor and uses thereof in medicine
07/02/2009US20090170895 S1p3 receptor antagonist
07/02/2009US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170108 Screening method, a composition comprising substances chosen in the method thereof, and a binding substance
07/02/2009DE102007063507A1 Verfahren zur Herstellung von Carbonsäureestern Process for the preparation of carboxylic acid esters
07/02/2009CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy
07/01/2009EP2075247A1 Fluorinated monomer having cyclic structure, manufaturing method, polymer, photoresist composition and patterning process
07/01/2009EP2075244A1 New route to building block for making renin inhibitors
07/01/2009EP2074107A2 Tricyclic compounds as matrix metalloproteinase inhibitors
07/01/2009EP2074106A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10
07/01/2009EP2074102A1 2-phenyl indene derivatives useful as estrogen receptor ligands
07/01/2009EP2074097A2 Compounds for treating proliferative disorders
07/01/2009EP1756043B1 Ortho substituted aryl or heteroaryl amide compounds
07/01/2009EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers
07/01/2009EP1487577B1 Catalyst-precursor for the production of maleic acid anhydride and method for the production thereof
07/01/2009EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
07/01/2009EP1406858B1 Substituted 4-aminocyclohexanols
07/01/2009CN101468975A High-purity salvianolic acid B, preparation and use thereof
07/01/2009CN100506812C Method for producing furol by extruding plant stalk
07/01/2009CN100506788C Arylalkylcarbamate derivatives production and use thereof in therapy
06/2009
06/30/2009US7553988 Method for producing coupling compound
06/30/2009US7553970 Process for preparing 3-heteroaryl-3-hydroxypropanoic acid derivatives
06/30/2009US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/30/2009US7553867 Furan or thiophene derivative and medicinal use thereof
06/30/2009US7553831 Beta-secretase inhibitors; inhibiting cleavage of amyloid precursor protein (APP); hydroxy-functional disubstituted amines such as 6-(([[(2S,3S)-4-(3,5-difluorophenyl)-3-((3-[(dipropylamino)carbonyl]benzoyl)amino)-2-hydroxybutyl](ethyl)amino]carbonyl)amino)hexanoic acid
06/30/2009CA2406088C Novel phenyl-propargylether derivatives
06/25/2009WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor
06/25/2009WO2009077677A2 Novel polyspirane compounds, application thereof in the treatment of malaria or toxoplasmosis and method for preparing same
06/25/2009WO2009077606A2 Gasoline composition and process for the preparation of alkylfurfuryl ether
06/25/2009WO2009077587A1 Furan based resin, process for the preparation thereof, and use of the compound
06/25/2009WO2009076869A1 Salvianolic acid of high purity, preparation method and use thereof
06/25/2009WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
06/25/2009WO2009044143A3 Process for preparing benzofurans
06/25/2009WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors
06/25/2009US20090163726 Catalyst system for preparing carboxylic acids and/or carboxylic anhydrides
06/25/2009US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma
06/25/2009US20090163586 Bis-(Sulfonylamino) Derivatives in Therapy 205